Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,515 | 129,752 | 249,904 | 173,882 | 178,350 |
| Receivables | 182,575 | 215,570 | 184,880 | 285,873 | 171,163 |
| Inventories | 7,543 | 8,238 | 9,148 | 7,790 | 8,193 |
| TOTAL | $302,616 | $395,243 | $491,377 | $502,385 | $394,748 |
| Non-Current Assets | |||||
| PPE Net | 205,662 | 203,939 | 202,281 | 199,679 | 200,837 |
| Investments And Advances | 140,347 | 136,021 | 129,560 | 127,949 | 130,960 |
| Intangibles | 749,763 | 751,917 | 754,356 | 756,869 | 758,950 |
| Other Non-Current Assets | 139,801 | 136,499 | 140,273 | 139,633 | 183,080 |
| TOTAL | $1,235,573 | $1,228,376 | $1,226,470 | $1,224,130 | $1,273,827 |
| Total Assets | $1,538,189 | $1,623,619 | $1,717,847 | $1,726,515 | $1,668,575 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 64,459 | 48,095 | 50,864 | 47,692 | 44,146 |
| Accrued Expenses | 120,383 | 145,401 | 121,576 | 125,648 | 148,776 |
| Other current liabilities | 58,892 | 55,063 | 47,746 | 35,993 | 42,874 |
| TOTAL | $287,130 | $292,041 | $263,886 | $290,556 | $285,695 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 116,202 | 112,828 | 115,074 | 115,134 | 111,907 |
| TOTAL | $271,654 | $254,895 | $255,476 | $254,197 | $263,887 |
| Total Liabilities | $558,784 | $546,936 | $519,362 | $544,753 | $549,582 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,765 | 14,164 | 14,572 | 14,629 | 14,637 |
| Common Shares | 37,595 | 37,593 | 37,593 | 37,535 | 37,422 |
| Retained earnings | 2,955,375 | 2,887,123 | 2,831,540 | 2,786,264 | 2,721,832 |
| Other shareholders' equity | 2,238 | 1,900 | 2,187 | 2,544 | 2,563 |
| TOTAL | $979,405 | $1,076,683 | $1,198,485 | $1,181,762 | $1,118,993 |
| Total Liabilities And Equity | $1,538,189 | $1,623,619 | $1,717,847 | $1,726,515 | $1,668,575 |